This Biotech Stock Just Gapped Up To A Five-Year High; Here’s Why

Omeros stock rocketed to a five-year high Thursday on blowout second-quarter results for its new treatment for transplant complications.

The post This Biotech Stock Just Gapped Up To A Five-Year High; Here’s Why appeared first on Investor’s Business Daily.